A Hybrid Approach to Continuous Biomanufacturing of Biosimilars

Presented by

Andrew Falconbridge at Alvotech and Melisa Caprio at Repligen

About this talk

There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end operations are not fully realised yet there are opportunities to use these unit operations in a hybrid mode to increase output, reduce footprint and reduce the cost of goods. Data from experiments to show the effectiveness of these approaches
Related topics:

More from this channel

Upcoming talks (39)
On-demand talks (353)
Subscribers (36572)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.